Blog

Weight-loss drugs are forcing changes to grocery store offerings New food options targeting people taking drugs like Ozempic may change diets more broadly. Read More from the Global Wellness News ™

Sword Health Secures $130M for AI MSK Platform Moving well is a billion-dollar business. Read More from the Global Wellness News ™

Squared Circles Gets $40M To Launch New Health & Wellness Brands Backed by L Catterton, Squared Circles is eyeing projects including nutritious food products for GLP-1 users and whole-body health for men. Read More from the Global Wellness News ™

Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s Wellness App incentivizes healthy habits critical to whole-person health and longevity Read More from the Global Wellness News ™

Monk Lands £2M For Tech-Enabled Ice Baths Cold tubs are getting an upgrade. Read More from the Global Wellness News ™

Step aside BMI, body composition tests are on the rise. Here’s what to know If you dread getting on a scale to calculate your body mass index, there’s a good reason to ignore the measure. Body composition tests are an increasingly popular way to gauge health. Here’s why they’re better than BMI. Read More from the Global Wellness News ™

How Ozempic and GLP-1s Are Changing the Business of Travel The boom in weight loss drugs could have a massive impact on the travel industry, which we discuss in this issue of the Skift Travel Podcast. Read More from the Global Wellness News ™

The state of tourism and hospitality 2024 Tourism and hospitality are set to soar, powered by new travelers, destinations, and trends. Read More from the Global Wellness News ™

Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages The tool could be valuable for Americans scrambling to find GLP-1s, such as Novo Nordisk’s Wegovy and Ozempic. Read More from the Global Wellness News ™

Biosensor technology company Allez Health secures $60M The continuous glucose monitoring biosensor platform will use the funds to scale its manufacturing, move toward regulatory approval and perform more clinical trials. Read More from the Global Wellness News ™